TODAY STUDY

The TODAY study group brought together investigators in a collaborative effort involving institutions across the country to design and conduct a prospective, randomized trial to evaluate treatment regimens and the clinical course of type 2 diabetes in youth. In order to be eligible to be in the study, participants had to have type 2 diabetes diagnosed according to American Diabetes Association criteria within the previous 2 years, absence of islet autoantibodies, BMI >= 85 th percentile, age 10-17 years, and a family member willing to participate in the child's treatment. A total of 699 participants were enrolled from 2004-2009 and followed for 2 to 6 years... Randomized clinical trial comparing efficacy and safety of three interventions to treat adolescents and youth with type 2 diabetes, involving institutions across the US.